MAZE THERAPEUTICS, INC. (MAZE) Free cash flow 2024–2025
MAZE THERAPEUTICS, INC. (MAZE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$112.7MFY2025 · since FY2024: $74.8M → -$112.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$112.7M | -250.7% |
| FY2024 | $74.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MAZE financial trends
MAZE RevenueMAZE Net incomeMAZE Net marginMAZE Gross profitMAZE Gross marginMAZE Operating incomeMAZE Operating marginMAZE Operating cash flowMAZE Capital expendituresMAZE Return on equityMAZE Stock buybacksMAZE Dividends paidMAZE Total assetsMAZE Total liabilitiesMAZE Shareholders’ equityMAZE overview →